vTv Therapeutics Inc (VTVT): Lol right

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

vTv Therapeutics Inc (VTVT)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	30
Posts	5708
Boards Moderated	0
Alias Born	02/13/2019

Re: Investor2014 post# 425

Friday, 05/24/2019 6:47:35 PM

Friday, May 24, 2019 6:47:35 PM

Lol right

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent VTVT News

CANTEX PHARMACEUTICALS TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA DRUG DEVELOPMENT SUMMIT • PR Newswire (US) • 03/19/2024 12:30:00 PM
vTv Therapeutics Announces 2023 Fourth Quarter and Full Year Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/13/2024 12:00:00 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 09:47:37 PM
Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 03/06/2024 12:52:29 AM
Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 01:04:31 PM
vTv Therapeutics Announces FDA Submission for First Phase 3 Study of Cadisegliatin in Patients with Type 1 Diabetes • GlobeNewswire Inc. • 03/04/2024 01:00:00 PM
vTv Therapeutics to Participate at the TD Cowen 44th Annual Healthcare Conference • GlobeNewswire Inc. • 03/01/2024 01:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 02:26:55 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/28/2024 02:14:12 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 01:08:30 PM
vTv Therapeutics Announces $51 Million Private Placement from Healthcare-focused Institutional Investors and the JDRF T1D Fund • GlobeNewswire Inc. • 02/28/2024 01:00:00 PM
CANTEX PHARMACEUTICALS TO PARTICIPATE IN THE BIO CEO & INVESTOR CONFERENCE • PR Newswire (US) • 02/22/2024 09:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/22/2023 09:26:26 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2023 09:28:15 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:21:45 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2023 09:23:40 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 01:22:56 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 01:19:26 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:31 PM
vTv Therapeutics Announces 2023 Third Quarter Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 11/09/2023 09:30:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 09:20:16 PM
vTv Therapeutics to Participate at the Stifel 2023 Healthcare Conference • GlobeNewswire Inc. • 11/08/2023 01:00:00 PM
vTv Therapeutics Appoints Thomas Strack, M.D., as Chief Medical Officer • GlobeNewswire Inc. • 11/02/2023 12:00:54 PM

More VTVT News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow